An infectious bronchitis recombinant virus lacking e protein ion channel activity and its preparation method and application
A bronchitis and ion channel technology, applied in the field of molecular biology, can solve the problems of virion morphological defects, decreased titer, increased apoptosis, etc., and achieves effects of major public health and economic significance
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0096] Example 1 IBV infectious cDNA clone based on seamless cloning technology
[0097] Based on the seamless technology, the E protein gene locus sequence of infectious bronchitis virus was mutated to obtain five fragments spanning the entire IBV genome, namely fragment A, fragment B, fragment C, fragment D and fragment E, Restriction sites were introduced into the 5' and 3' ends of the five fragments, combined with the T7 promoter, ligated in vitro to obtain clones, and transcribed in vitro to obtain full-length RNA (such as figure 1 shown); the specific steps are as follows:
[0098] (1) Infect African green monkey kidney cells (Vero cells, ATCC) with chicken IBV. For the source and infection method of IBV, see the literature "S. Shen, et al. Emergence of a coronavirus infectious bronchitis virus mutant with a truncated 3b gene: functional characterization of the 3b protein inpathogenesis and replication.”.
[0099] (2) The total RNA extracted from IBV-infected African g...
Embodiment 2
[0114] Embodiment 2 The recombination and purification method of rIBV-A26F lacking E protein ion channel activity comprises the following steps:
[0115] (1) First, the E protein gene locus sequence of infectious bronchitis virus is deleted by seamless cloning technology, combined with the T7 promoter, and connected in vitro to obtain a complete RNA clone; then the above clone is infectiously cloned, The cloned sequence to be obtained is introduced into Vero cells by electroporation to obtain infectious bronchitis recombinant virus lacking E protein ion channel activity: the specific operation is the same as
[0116] Example 1.
[0117] (2) The cell supernatant infected with rIBV-A26F was collected, then diluted 10 times with serum-free DMEM, and the virus titer was tested by plaque purification experiment.
[0118] (3) Infect the diluted supernatant virus into a 6-well Vero cell plate, after 2 hours the virus is adsorbed, the supernatant is removed, and the cells are washed ...
Embodiment 3
[0124] Example 3 Stability Analysis of IBV Mutant Attenuated Strain Adapted to Vero Cells Deleting E Protein Ion Channel Activity
[0125] (1) Infect Vero cells with the rIBV-A26F mutant virus, culture at 37°C for 24 hours, collect the supernatant, and then use the supernatant virus to infect newly plated Vero cells, and so on to infect 30 generations;
[0126] (2) Collect, lyse and extract cellular RNA after the 5th, 10th, 15th, 20th, 25th, and 30th generations of virus infection, RT-PCR, E gene sequencing, and compare the sequences to see if there is a new mutation in the E gene, thereby To determine the genetic stability of the strain, the primers of the amplified E gene are the same as those in Table 2, and the sequencing primers are upstream primers.
[0127] (3) Analysis of sequencing results. From the 10th generation onwards, the second T of the 26th amino acid phenylalanine of the rIBV-A26F mutant virus was gradually replaced by C, and the original TTT codon was conver...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com